Kampala, Uganda | THE INDEPENDENT | Leading drug manufacturing firms, Sanofi and GlaxoSmithKline, have entered into an agreement to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies to help address the ongoing pandemic. Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA technology. …
Read More »